Autopsy report · NCT05112835

Brolucizumab Treatment Experience Study of Patients With nAMD in UK Routine Clinical Practice

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.

“Sponsor decision”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 10 months before it stopped.
302 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Sponsor: Novartis Pharmaceuticals
Sponsor type: Industry
Conditions: Neovascular Age-related Macular Degeneration
Interventions: brolucizumab
Participants: 302
Sites: 17
Countries: United Kingdom

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.